Loading company…
Beijing genetic testing company offering pre-implantation and prenatal screening services for fertility clinics and healthcare providers.
Peking Jabrehoo Med Tech provides genetic testing and reproductive health services, including pre-implantation genetic testing for aneuploidy, single-gene disorders and chromosomal rearrangements, plus prenatal screening and non-invasive prenatal testing. Founded in 2011 in Beijing, China, it charges per test to fertility clinics and healthcare institutions, mainly in Asia and Europe. It raised RMB 100 million in Series B funding on August 10, 2020, primarily from Apricot Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in